167 related articles for article (PubMed ID: 22274917)
1. Identification of a 7-gene signature that predicts relapse and survival for early stage patients with cervical carcinoma.
Huang L; Zheng M; Zhou QM; Zhang MY; Yu YH; Yun JP; Wang HY
Med Oncol; 2012 Dec; 29(4):2911-8. PubMed ID: 22274917
[TBL] [Abstract][Full Text] [Related]
2. Utility of a metabolic-associated nomogram to predict the recurrence-free survival of stage I cervical cancer.
Zhang Y; Lu H; Zhang J; Wang S
Future Oncol; 2021 Apr; 17(11):1325-1337. PubMed ID: 33631974
[TBL] [Abstract][Full Text] [Related]
3. Analysis of prognostic variables, development of predictive models, and stratification of risk groups in surgically treated FIGO early-stage (IA-IIA) carcinoma cervix.
Singh P; Tripcony L; Nicklin J
Int J Gynecol Cancer; 2012 Jan; 22(1):115-22. PubMed ID: 21997176
[TBL] [Abstract][Full Text] [Related]
4. A seven-long noncoding RNA signature predicts relapse in patients with early-stage lung adenocarcinoma.
Zhou H; Zhang H; Chen J; Cao J; Liu L; Guo C; Huang G; Zeng D
J Cell Biochem; 2019 Sep; 120(9):15730-15739. PubMed ID: 31050375
[TBL] [Abstract][Full Text] [Related]
5. [Prognostic analysis of stage Ⅰb2 andⅡa2 cervical squamous cancer without high risk factors treated with neo-adjuvant chemotherapy and radical hysterectomy].
Li PP; Li B; Wang YT; Liu SH; Zhang YN; Zhang R; Bai P; Li XG; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2018 Apr; 53(4):248-256. PubMed ID: 29747270
[No Abstract] [Full Text] [Related]
6. [Analysis of prognostic factors and therapeutic patterns of recurrent stage Ⅰb-Ⅱa cervical squamous carcinoma treated with radical hysterectomy].
Ou ZJ; Zhao D; An JS; Sun CY; Huang MN; Li B; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2019 Jun; 54(6):399-405. PubMed ID: 31262124
[No Abstract] [Full Text] [Related]
7. Postoperative nomogram for the prediction of disease-free survival in lymph node-negative stage I-IIA cervical cancer patients treated with radical hysterectomy.
Gülseren V; Kocaer M; Çakır İ; Özdemir İA; Sancı M; Güngördük K
J Obstet Gynaecol; 2020 Jul; 40(5):699-704. PubMed ID: 31607197
[TBL] [Abstract][Full Text] [Related]
8. A 10-gene prognostic methylation signature for stage I-III cervical cancer.
Cai S; Yu X; Gu Z; Yang Q; Wen B; Sheng J; Guan R
Arch Gynecol Obstet; 2020 May; 301(5):1275-1287. PubMed ID: 32274635
[TBL] [Abstract][Full Text] [Related]
9. Genetic profiling to predict recurrence of early cervical cancer.
Lee YY; Kim TJ; Kim JY; Choi CH; Do IG; Song SY; Sohn I; Jung SH; Bae DS; Lee JW; Kim BG
Gynecol Oncol; 2013 Dec; 131(3):650-4. PubMed ID: 24145113
[TBL] [Abstract][Full Text] [Related]
10. Preoperative prognostic variables and the impact of postoperative adjuvant therapy on the outcomes of Stage IB or II cervical carcinoma patients with or without pelvic lymph node metastases: an analysis of 891 cases.
Lai CH; Hong JH; Hsueh S; Ng KK; Chang TC; Tseng CJ; Chou HH; Huang KG
Cancer; 1999 Apr; 85(7):1537-46. PubMed ID: 10193944
[TBL] [Abstract][Full Text] [Related]
11. Clusterin expression predicts survival of invasive cervical cancer patients treated with radical hysterectomy and systematic lymphadenectomy.
Watari H; Ohta Y; Hassan MK; Xiong Y; Tanaka S; Sakuragi N
Gynecol Oncol; 2008 Mar; 108(3):527-32. PubMed ID: 18177691
[TBL] [Abstract][Full Text] [Related]
12. Identification and validation of a six-gene signature associated with glycolysis to predict the prognosis of patients with cervical cancer.
Cai L; Hu C; Yu S; Liu L; Yu X; Chen J; Liu X; Lin F; Zhang C; Li W; Yan X
BMC Cancer; 2020 Nov; 20(1):1133. PubMed ID: 33228592
[TBL] [Abstract][Full Text] [Related]
13. The tumor-stroma ratio is an independent predictor of survival in patients with 2018 FIGO stage IIIC squamous cell carcinoma of the cervix following primary radical surgery.
Zong L; Zhang Q; Kong Y; Yang F; Zhou Y; Yu S; Wu M; Chen J; Zhang Y; Xiang Y
Gynecol Oncol; 2020 Mar; 156(3):676-681. PubMed ID: 31882242
[TBL] [Abstract][Full Text] [Related]
14. Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.
Luo M; Shen D; Wang W; Xian J
Int J Clin Exp Pathol; 2015; 8(5):5542-8. PubMed ID: 26191262
[TBL] [Abstract][Full Text] [Related]
15. Preoperative prognostic factors and effects of adjuvant therapy on outcomes of early stage cervical cancer in Iran.
Behtash N; Karimi Zarchi M; Deldar M
Asian Pac J Cancer Prev; 2009; 10(4):613-8. PubMed ID: 19827880
[TBL] [Abstract][Full Text] [Related]
16. A gene expression signature that can predict the recurrence of tamoxifen-treated primary breast cancer.
Chanrion M; Negre V; Fontaine H; Salvetat N; Bibeau F; Mac Grogan G; Mauriac L; Katsaros D; Molina F; Theillet C; Darbon JM
Clin Cancer Res; 2008 Mar; 14(6):1744-52. PubMed ID: 18347175
[TBL] [Abstract][Full Text] [Related]
17. The prognostic role of horizontal and circumferential tumor extent in cervical cancer: Implications for the 2019 FIGO staging system.
Zyla RE; Gien LT; Vicus D; Olkhov-Mitsel E; Mirkovic J; Nofech-Mozes S; Djordjevic B; Parra-Herran C
Gynecol Oncol; 2020 Aug; 158(2):266-272. PubMed ID: 32471646
[TBL] [Abstract][Full Text] [Related]
18. A 10-gene prognostic signature points to LIMCH1 and HLA-DQB1 as important players in aggressive cervical cancer disease.
Halle MK; Sødal M; Forsse D; Engerud H; Woie K; Lura NG; Wagner-Larsen KS; Trovik J; Bertelsen BI; Haldorsen IS; Ojesina AI; Krakstad C
Br J Cancer; 2021 May; 124(10):1690-1698. PubMed ID: 33723390
[TBL] [Abstract][Full Text] [Related]
19. Identification of a novel six-gene signature with potential prognostic and therapeutic value in cervical cancer.
Qu X; Shi Z; Guo J; Guo C; Qiu J; Hua K
Cancer Med; 2021 Oct; 10(19):6881-6896. PubMed ID: 34498424
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors in neuroendocrine small cell cervical carcinoma: a multivariate analysis.
Chan JK; Loizzi V; Burger RA; Rutgers J; Monk BJ
Cancer; 2003 Feb; 97(3):568-74. PubMed ID: 12548598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]